UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Offline analysis of the relaxed upper boundedness for online estimation ofoptimal event sequences in Partially Observable Petri Nets

Discrete event dynamic systems, 2024, Vol.34 (2), p.351-374

Declerck, P.

2024

Volltextzugriff (PDF)

Counter approach for the estimation of optimal sequences in Partially Observable Untimed Petri Nets

Discrete event dynamic systems, 2021-12, Vol.31 (4), p.489-512

Declerck, P.

2021

Volltextzugriff (PDF)

Two-staged approach for estimation of sequences in partially observable P-time Petri nets on a sliding horizon with schedulability analysis

International journal of control, 2024-06, Vol.97 (6), p.1341-1350

2024

Volltextzugriff (PDF)

Identification of a bacterial inhibitor against g-type lysozyme

Cellular and molecular life sciences : CMLS, 2011-03, Vol.68 (6), p.1053-1064

2011

Volltextzugriff (PDF)

Generation of a stable thrombin‐activatable fibrinolysis inhibitor deletion mutant exerting full carboxypeptidase activity without activation

Journal of thrombosis and haemostasis, 2015-06, Vol.13 (6), p.1084-1089

2015

Volltextzugriff (PDF)

Amplified endogenous plasmin activity resolves acute thrombotic thrombocytopenic purpura in mice

Journal of thrombosis and haemostasis, 2017-12, Vol.15 (12), p.2432-2442

2017

Volltextzugriff (PDF)

Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin‐activatable fibrinolysis inhibitor activation and activated thrombin‐activatable fibrinolysis inhibitor activity

Journal of thrombosis and haemostasis, 2016-08, Vol.14 (8), p.1629-1638

2016

Volltextzugriff (PDF)

Critical subsystems in time interval models: Application to a baking process

Discrete event dynamic systems, 2021-03, Vol.31 (1), p.25-35

Declerck, P.

2021

Volltextzugriff (PDF)

Modelling Black Carbon concentrations in two busy street canyons in Brussels using CANSBC

Atmospheric environment (1994), 2015-01, Vol.101, p.72-81

2015

Volltextzugriff (PDF)

Plasmin and the thrombin–thrombomodulin complex both contribute to thrombin‐activatable fibrinolysis inhibitor activation in whole blood model thrombi

Journal of thrombosis and haemostasis, 2013-01, Vol.11 (1), p.190-192

2013

Volltextzugriff (PDF)

Lysozyme inhibitor conferring bacterial tolerance to invertebrate type lysozyme

Cellular and molecular life sciences : CMLS, 2010-04, Vol.67 (7), p.1177-1188

2010

Volltextzugriff (PDF)

Development of a high throughput cross-flow filtration system for detailed investigation of fouling processes

Journal of membrane science, 2013-09, Vol.442, p.168-176

2013

Volltextzugriff (PDF)

The pro‐ or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent

The FASEB journal, 2002-02, Vol.16 (2), p.147-154

2002

Volltextzugriff (PDF)

Biofouling on microfiltration membranes in MBRs: Role of membrane type and microbial community

Journal of membrane science, 2014-03, Vol.453, p.394-401

2014

Volltextzugriff (PDF)

The hyperfibrinolytic state of mice with combined thrombin‐activatable fibrinolysis inhibitor (TAFI) and plasminogen activator inhibitor‐1 gene deficiency is critically dependent on TAFI deficiency

Journal of thrombosis and haemostasis, 2012-12, Vol.10 (12), p.2555-2562

2012

Volltextzugriff (PDF)

Monoclonal antibodies targeting the antifibrinolytic activity of activated thrombin‐activatable fibrinolysis inhibitor but not the anti‐inflammatory activity on osteopontin and C5a

Journal of thrombosis and haemostasis, 2013-12, Vol.11 (12), p.2137-2147

2013

Volltextzugriff (PDF)

Generation and characterization of inhibitory nanobodies towards thrombin activatable fibrinolysis inhibitor

Journal of thrombosis and haemostasis, 2010-06, Vol.8 (6), p.1302-1312

2010

Volltextzugriff (PDF)

Thrombin activatable fibrinolysis inhibitor

Hämostaseologie, 2011, Vol.31 (3), p.165-173

Declerck, P J

2011

Volltextzugriff (PDF)

Evaluation of the profibrinolytic properties of a bispecific antibody‐based inhibitor against human and mouse thrombin‐activatable fibrinolysis inhibitor and plasminogen activator inhibitor‐1

Journal of thrombosis and haemostasis, 2013-11, Vol.11 (11), p.2069-2071

2013

Volltextzugriff (PDF)

Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth

Oncogene, 2004-09, Vol.23 (41), p.6986-6990

2004

Volltextzugriff (PDF)

Critical subsystems in time interval models

Discrete event dynamic systems, 2021-01, Vol.31 (1), p.25-35

Declerck, P

2021

Volltextzugriff (PDF)

Identification of a novel, nanobody‐induced, mechanism of TAFI inactivation and its in vivo application

Journal of thrombosis and haemostasis, 2014-02, Vol.12 (2), p.229-236

2014

Volltextzugriff (PDF)

Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis

British journal of cancer, 2000-05, Vol.82 (10), p.1702-1708

2000

Volltextzugriff (PDF)

Systemic inhibition and liver‐specific over‐expression of PAI‐1 failed to improve survival in all‐inclusive populations or homogenous cohorts of CLP mice

Journal of thrombosis and haemostasis, 2014-06, Vol.12 (6), p.958-969

2014

Volltextzugriff (PDF)

The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study

Journal of thrombosis and haemostasis, 2009-06, Vol.7 (6), p.919-927

2009

Volltextzugriff (PDF)

1 – 25 von 683

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(574)
Mit Volltextzugriff
(534)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(447)
Life Sciences & Biomedicine
(395)
Humans
(274)
Biological And Medical Sciences
(183)
Animals
(115)
Female
(114)
Medical Sciences
(113)
Male
(103)
Hematology
(89)
Cardiovascular System & Cardiology
(86)
Biochemistry & Molecular Biology
(78)
Fundamental And Applied Biological Sciences. Psychology
(77)
Peripheral Vascular Disease
(76)
Middle Aged
(71)
Adult
(69)
Technology
(55)
Fibrinolysis
(49)
Mice
(42)
Aged
(38)
Physical Sciences
(38)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Offline analysis of the relaxed upper boundedness for online estimation ofoptimal event sequences in Partially Observable Petri Nets

Counter approach for the estimation of optimal sequences in Partially Observable Untimed Petri Nets

Two-staged approach for estimation of sequences in partially observable P-time Petri nets on a sliding horizon with schedulability analysis

Identification of a bacterial inhibitor against g-type lysozyme

Generation of a stable thrombin‐activatable fibrinolysis inhibitor deletion mutant exerting full carboxypeptidase activity without activation

Amplified endogenous plasmin activity resolves acute thrombotic thrombocytopenic purpura in mice

Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin‐activatable fibrinolysis inhibitor activation and activated thrombin‐activatable fibrinolysis inhibitor activity

Critical subsystems in time interval models: Application to a baking process

Modelling Black Carbon concentrations in two busy street canyons in Brussels using CANSBC

Plasmin and the thrombin–thrombomodulin complex both contribute to thrombin‐activatable fibrinolysis inhibitor activation in whole blood model thrombi

Lysozyme inhibitor conferring bacterial tolerance to invertebrate type lysozyme

Development of a high throughput cross-flow filtration system for detailed investigation of fouling processes

The pro‐ or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent

Biofouling on microfiltration membranes in MBRs: Role of membrane type and microbial community

The hyperfibrinolytic state of mice with combined thrombin‐activatable fibrinolysis inhibitor (TAFI) and plasminogen activator inhibitor‐1 gene deficiency is critically dependent on TAFI deficiency

Monoclonal antibodies targeting the antifibrinolytic activity of activated thrombin‐activatable fibrinolysis inhibitor but not the anti‐inflammatory activity on osteopontin and C5a

Generation and characterization of inhibitory nanobodies towards thrombin activatable fibrinolysis inhibitor

Thrombin activatable fibrinolysis inhibitor

Evaluation of the profibrinolytic properties of a bispecific antibody‐based inhibitor against human and mouse thrombin‐activatable fibrinolysis inhibitor and plasminogen activator inhibitor‐1

Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth

Critical subsystems in time interval models

Identification of a novel, nanobody‐induced, mechanism of TAFI inactivation and its in vivo application

Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis

Systemic inhibition and liver‐specific over‐expression of PAI‐1 failed to improve survival in all‐inclusive populations or homogenous cohorts of CLP mice

The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study

Suchergebnisse filtern